Summary
35 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Revenue grew by 15% a year over the last 3 years.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
Revenue grew by 10% a year over 5 years. Over the last 3 years it grew by 15% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $59.9K.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 22.0 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
- NovaVision 100%
By region
- UNITED STATES 100%
- Europe 0.3%
NovaVision brings in 100% of revenue.
Segments in detail